Logo for TC Biopharm Plc

TC Biopharm Investor Relations Material

Latest events

Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
TC Biopharm Plc is a UK-based clinical-stage biotechnology company developing cell-based immunotherapies for cancer treatment. The company focuses on gamma delta T cell therapies, aiming to treat hematologic malignancies and solid tumors. Its proprietary platform is based on allogeneic cell therapy designed for off-the-shelf use. The company is headquartered in Glasgow, United Kingdom, and its shares are listed on the OTCQB.